These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10401189)

  • 1. Human fascioliasis in Egyptian children: successful treatment with triclabendazole.
    el-Karaksy H; Hassanein B; Okasha S; Behairy B; Gadallah I
    J Trop Pediatr; 1999 Jun; 45(3):135-8. PubMed ID: 10401189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect of triclabendazole in patients with fascioliasis in Egypt. A preliminary study.
    Hammouda NA; el-Mansoury ST; el-Azzouni MZ; el-Gohari Y
    J Egypt Soc Parasitol; 1995 Apr; 25(1):137-43. PubMed ID: 7602156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A praziquantel-ineffective fascioliasis case successfully treated with triclabendazole.
    Ishii Y; Nakamura-Uchiyama F; Nawa Y
    Parasitol Int; 2002 Jun; 51(2):205-9. PubMed ID: 12113760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fasciola hepatica infection. Successful therapy using triclabendazole].
    Markwalder K; Koller M; Goebel N; Wolff K
    Schweiz Med Wochenschr; 1988 Jul; 118(27-28):1048-52. PubMed ID: 3413464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response.
    Apt W; Aguilera X; Vega F; Miranda C; Zulantay I; Perez C; Gabor M; Apt P
    Am J Trop Med Hyg; 1995 Jun; 52(6):532-5. PubMed ID: 7611560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru: A Case Series.
    Cabada MM; Lopez M; Cruz M; Delgado JR; Hill V; White AC
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004361. PubMed ID: 26808543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe iron deficiency anemia and marked eosinophilia in adolescent girls with the diagnosis of human fascioliasis.
    Tavil B; Ok-Bozkaya İ; Tezer H; Tunç B
    Turk J Pediatr; 2014; 56(3):307-9. PubMed ID: 25341606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic mass caused by Fasciola hepatica: a tricky differential diagnosis.
    Yilmaz B; Köklü S; Gedikoglu G
    Am J Trop Med Hyg; 2013 Dec; 89(6):1212-3. PubMed ID: 24080633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic fascioliasis: case report and review.
    Abdul-Hadi S; Contreras R; Tombazzi C; Alvarez M; Melendez M
    Rev Inst Med Trop Sao Paulo; 1996; 38(1):69-73. PubMed ID: 8762643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pediatric case of Fascioliasis with eosinophilic pneumonia.
    Bayhan Gİ; Batur A; Taylan-Özkan A; Demirören K; Beyhan YE
    Turk J Pediatr; 2016; 58(1):109-112. PubMed ID: 27922247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obstructive jaundice with fever and eosinophilia.
    Inoue K; Kanemasa H; Inoue K; Matsumoto M; Kajita Y; Mitsufuji S; Kataoka K; Okanoue T; Yamada M; Uchikawa R; Tegoshi T; Arizono N
    Gut; 2007 Nov; 56(11):1542, 1571. PubMed ID: 17938433
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of triclabendazole for treatment of patients co-infected by Fasciola spp. and S. mansoni in Behera Governorate, Egypt.
    Barduagni P; Hassanein Y; Mohamed M; Wakeel AE; Sayed ME; Hallaj Z; Curtale F
    Parasitol Res; 2008 Mar; 102(4):631-3. PubMed ID: 18071750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies on the effect of Bithionol, Praziquantel and Triclabendazole in rabbit's fascioliasis.
    el Sayad MH
    J Egypt Soc Parasitol; 1997 Dec; 27(3):925-6. PubMed ID: 9425836
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized trial of a single, double and triple dose of 10 mg/kg of a human formulation of triclabendazole in patients with fascioliasis.
    Talaie H; Emami H; Yadegarinia D; Nava-Ocampo AA; Massoud J; Azmoudeh M; Mas-Coma S
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):777-82. PubMed ID: 15566392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cases of human fascioliasis in India: tip of the iceberg.
    Ramachandran J; Ajjampur SS; Chandramohan A; Varghese GM
    J Postgrad Med; 2012; 58(2):150-2. PubMed ID: 22718061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Fasciola hepatica infection in horses with triclabendazole.
    Rubilar L; Cabreira A; Giacaman L
    Vet Rec; 1988 Sep; 123(12):320-1. PubMed ID: 3195012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Praziquantel and Fasciola hepatica infection.
    Ripert CL
    Trans R Soc Trop Med Hyg; 1990; 84(4):610. PubMed ID: 2091367
    [No Abstract]   [Full Text] [Related]  

  • 18. Human fascioliasis: a re-emerging disease in upper Egypt.
    Mekky MA; Tolba M; Abdel-Malek MO; Abbas WA; Zidan M
    Am J Trop Med Hyg; 2015 Jul; 93(1):76-9. PubMed ID: 25870421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human fascioliasis successfully treated with triclabendazole.
    Laird PP; Boray JC
    Aust N Z J Med; 1992 Feb; 22(1):45-7. PubMed ID: 1580862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole.
    Graham CS; Brodie SB; Weller PF
    Clin Infect Dis; 2001 Jul; 33(1):1-5. PubMed ID: 11389487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.